{"slideshow_credits": null, "snippet": "The pharmaceutical giant\u2019s $15 billion purchase of Hospira should bolster Pfizer\u2019s own generics unit \u2013 and open the way for spinning it off, says Robert Cyran of Reuters Breakingviews.", "abstract": "The pharmaceutical giant\u2019s $15 billion purchase of Hospira should bolster Pfizer\u2019s own generics unit \u2013 and open the way for spinning it off, says Robert Cyran of Reuters Breakingviews.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Robert", "role": "reported", "lastname": "CYRAN", "rank": 1, "organization": ""}], "original": "By ROBERT CYRAN"}, "web_url": "http://dealbook.nytimes.com/2015/02/05/a-deal-that-could-reverse-pfizers-history-of-value-destroying-acquisitions/", "lead_paragraph": null, "headline": {"main": "A Deal That Could Reverse Pfizer's History of Value-Destroying Acquisitions", "kicker": "DealBook"}, "_id": "54d3c03838f0d873d358e478", "word_count": "391", "multimedia": [{"height": 126, "url": "images/2015/02/06/business/dbpix-drug-hospira1/dbpix-drug-hospira1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/02/06/business/dbpix-drug-hospira1/dbpix-drug-hospira1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 800, "url": "images/2015/02/06/business/dbpix-drug-hospira1/dbpix-drug-hospira1-articleLarge.jpg", "legacy": {"xlarge": "images/2015/02/06/business/dbpix-drug-hospira1/dbpix-drug-hospira1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "800"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/02/06/business/dbpix-drug-hospira1/dbpix-drug-hospira1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/02/06/business/dbpix-drug-hospira1/dbpix-drug-hospira1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-02-05T14:10:05Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Read, Ian C", "rank": "1"}, {"name": "organizations", "value": "Hospira Inc", "rank": "1"}, {"name": "organizations", "value": "Pfizer Inc", "rank": "2"}, {"name": "organizations", "value": "Warner-Lambert Co", "rank": "3"}, {"name": "subject", "value": "Biotechnology and Bioengineering", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "3"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}